Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice
- PMID: 8212824
- DOI: 10.1016/0264-410x(93)90130-p
Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice
Abstract
In studies of infection of young Balb/c mice with a mouse virulent strain of X-31 (H3N2) influenza A virus we have shown a profound virus dose-related effect of infection on body weight. Most of this effect is prevented by prior administration of either inactivated whole virus vaccine, which prevents infection, or purified influenza virus neuraminidase, which is infection-permissive, but reduces pulmonary virus replication by 1.5 to 3 orders of magnitude. These studies support the concept of infection-permissive immunization and suggest that levels of virus replication previously shown to be antigenic can be sustained without significant systemic effects.
Similar articles
-
Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.J Infect Dis. 1990 Oct;162(4):800-9. doi: 10.1093/infdis/162.4.800. J Infect Dis. 1990. PMID: 2401790
-
Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.Vaccine. 1999 Apr 9;17(15-16):2073-80. doi: 10.1016/s0264-410x(98)00413-7. Vaccine. 1999. PMID: 10217609
-
Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.Vaccine. 1998 May-Jun;16(9-10):1009-15. doi: 10.1016/s0264-410x(97)00279-x. Vaccine. 1998. PMID: 9682352
-
Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.Jpn J Infect Dis. 2000 Dec;53(6):219-28. Jpn J Infect Dis. 2000. PMID: 11227019 Review.
-
Influenza vaccine immunology.Immunol Rev. 2011 Jan;239(1):167-77. doi: 10.1111/j.1600-065X.2010.00974.x. Immunol Rev. 2011. PMID: 21198671 Review.
Cited by
-
Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine.Vaccines (Basel). 2020 Jul 23;8(3):409. doi: 10.3390/vaccines8030409. Vaccines (Basel). 2020. PMID: 32718039 Free PMC article. Review.
-
Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity.J Virol. 2010 Mar;84(5):2408-20. doi: 10.1128/JVI.02135-09. Epub 2009 Dec 23. J Virol. 2010. PMID: 20032181 Free PMC article.
-
Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.Vaccine. 2016 Jan 4;34(2):218-224. doi: 10.1016/j.vaccine.2015.11.037. Epub 2015 Nov 25. Vaccine. 2016. PMID: 26620838 Free PMC article.
-
A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model.Front Immunol. 2022 Jul 7;13:915364. doi: 10.3389/fimmu.2022.915364. eCollection 2022. Front Immunol. 2022. PMID: 35874791 Free PMC article.
-
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.Elife. 2024 Sep 25;13:RP91849. doi: 10.7554/eLife.91849. Elife. 2024. PMID: 39319780 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical